GlaxoSmithKline Standardizes on BioClinica Trident IWR Solution
BioClinica®, Inc., (NASDAQ: BIOC) announced that GlaxoSmithKline LLC (“GSK”) has signed a multi-year enterprise technology agreement to deploy BioClinica’s Trident IWR (Interactive Web Response) system across its Phase I-IV clinical trials.
“GSK had a requirement for a new solution to enable internal staff to configure and manage highly complex IWR clinical studies, and we are pleased GSK chose Trident,” said Mark Weinstein, CEO of BioClinica. “We look forward to supporting GSK so that they can successfully deploy and utilize our software in their upcoming studies.”
Trident IWR’s design provides clinical operations personnel with a way to directly set up, monitor, and maintain randomization and supplies for their clinical trials, in less time than previously required. Trident IWR delivers rapid study setup without the need for programming, while delivering IVR (Interactive Voice Response) system phone support through the same configuration process.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
